Tuesday, July 29, 2014 Last update: 1:33 PM
FreshNews.com - All Company Technology News Since 1996

Emergent BioSolutions to Participate in June 2014 Investor Conferences

Companies mentioned in this article: Emergent BioSolutions Inc.

ROCKVILLE, Md. -- (BUSINESS WIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences in June 2014:

  • Jefferies 2014 Global Healthcare Conference
    New York, NY
    June 5, 2014
    Presentation: 1:00PM Eastern
  • JMP Securities Healthcare Conference
    New York, NY
    June 24, 2014
    Presentation: 4:00PM Eastern
  • Janney Capital Markets’ Boston Healthcare Corporate Access Day
    Boston, MA
    June 26, 2014

For the Jefferies and JMP Securities conferences, the company will be webcasting the formal portion of its participation, which may include a discussion of the company's recent business developments as well as its current financial results and financial guidance for the current year and latest quarterly period. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”

For the Janney Capital Markets conference, the company will only be participating in one-on-one meetings. The conference format does not include formal presentations.

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.


Copyright © Business Wire 2014
Contact:

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Global Public Affairs and Corporate Responsibility
301-795-1800
SchmittT@ebsi.com